Keio University to Collaborate with SOCIUM Inc. Strategic partnership aims to AI-driven drug discovery for Aging-Related Diseases

SOCIUM Inc. announced that SOCIUM Inc. (Head office: Chuo-ku, Tokyo, CEO: Dr. Hiroshi Kawai) has entered into a joint research agreement with Keio University (Motoshi Hayano, Assistant Professor, Department of Neuropsychiatry, Keio University School of Medicine, Department of Technology and Engineering, Keio University) regarding AI-driven Drug Discovery for Aging-Related Diseases.

Click here for details (PDF).